These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30527799)

  • 21. HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
    Xu J; Lange EM; Lu L; Zheng SL; Wang Z; Thibodeau SN; Cannon-Albright LA; Teerlink CC; Camp NJ; Johnson AM; Zuhlke KA; Stanford JL; Ostrander EA; Wiley KE; Isaacs SD; Walsh PC; Maier C; Luedeke M; Vogel W; Schleutker J; Wahlfors T; Tammela T; Schaid D; McDonnell SK; DeRycke MS; Cancel-Tassin G; Cussenot O; Wiklund F; Grönberg H; Eeles R; Easton D; Kote-Jarai Z; Whittemore AS; Hsieh CL; Giles GG; Hopper JL; Severi G; Catalona WJ; Mandal D; Ledet E; Foulkes WD; Hamel N; Mahle L; Moller P; Powell I; Bailey-Wilson JE; Carpten JD; Seminara D; Cooney KA; Isaacs WB;
    Hum Genet; 2013 Jan; 132(1):5-14. PubMed ID: 23064873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.
    Laitinen VH; Wahlfors T; Saaristo L; Rantapero T; Pelttari LM; Kilpivaara O; Laasanen SL; Kallioniemi A; Nevanlinna H; Aaltonen L; Vessella RL; Auvinen A; Visakorpi T; Tammela TL; Schleutker J
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):452-60. PubMed ID: 23292082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.
    Schroeck FR; Zuhlke KA; Siddiqui J; Siddiqui R; Cooney KA; Wei JT
    J Urol; 2013 Mar; 189(3):849-53. PubMed ID: 23036981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
    Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB
    Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between germline HOXB13 G84E mutation and risk of prostate cancer.
    Akbari MR; Trachtenberg J; Lee J; Tam S; Bristow R; Loblaw A; Narod SA; Nam RK
    J Natl Cancer Inst; 2012 Aug; 104(16):1260-2. PubMed ID: 22781434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours.
    FitzGerald LM; Raspin K; Marthick JR; Field MA; Malley RC; Thomson RJ; Blackburn NB; Banks A; Charlesworth JC; Donovan S; Dickinson JL
    Sci Rep; 2017 Dec; 7(1):17778. PubMed ID: 29259341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.
    Smith SC; Palanisamy N; Zuhlke KA; Johnson AM; Siddiqui J; Chinnaiyan AM; Kunju LP; Cooney KA; Tomlins SA
    Am J Surg Pathol; 2014 May; 38(5):615-26. PubMed ID: 24722062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls.
    Shang Z; Zhu S; Zhang H; Li L; Niu Y
    Eur Urol; 2013 Jul; 64(1):173-6. PubMed ID: 23518396
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer.
    Alanee S; Shah S; Vijai J; Schrader K; Hamilton R; Rau-Murthy R; Sarrel K; Manschreck C; Eastham J; Offit K
    Fam Cancer; 2013 Dec; 12(4):597-600. PubMed ID: 23475555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline mutations in HOXB13 and prostate-cancer risk.
    Ewing CM; Ray AM; Lange EM; Zuhlke KA; Robbins CM; Tembe WD; Wiley KE; Isaacs SD; Johng D; Wang Y; Bizon C; Yan G; Gielzak M; Partin AW; Shanmugam V; Izatt T; Sinari S; Craig DW; Zheng SL; Walsh PC; Montie JE; Xu J; Carpten JD; Isaacs WB; Cooney KA
    N Engl J Med; 2012 Jan; 366(2):141-9. PubMed ID: 22236224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland.
    Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Gołąb A; Gliniewicz B; Sikorski A; Switała J; Borkowski T; Borkowski A; Antczak A; Wojnar L; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała P; Akbari MR; Lubiński J; Narod SA; Cybulski C;
    Prostate; 2013 Apr; 73(5):542-8. PubMed ID: 23334858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic factors influencing prostate cancer risk in Norwegian men.
    Chen H; Ewing CM; Zheng S; Grindedaal EM; Cooney KA; Wiley K; Djurovic S; Andreassen OA; Axcrona K; Mills IG; Xu J; Maehle L; Fosså SD; Isaacs WB
    Prostate; 2018 Feb; 78(3):186-192. PubMed ID: 29181843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients.
    Maia S; Cardoso M; Pinto P; Pinheiro M; Santos C; Peixoto A; Bento MJ; Oliveira J; Henrique R; Jerónimo C; Teixeira MR
    PLoS One; 2015; 10(7):e0132728. PubMed ID: 26176944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation HOXB13 c.853delT in Martinican prostate cancer patients.
    Marlin R; Créoff M; Merle S; Jean-Marie-Flore M; Rose M; Malsa S; Promeyrat X; Martin F; Comlan G; Rabia N; Taouil T; Issoufaly I; Escarmant P; Vinh-Hung V; Béra O
    Prostate; 2020 May; 80(6):463-470. PubMed ID: 32040869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.
    Liu J; Prager-van der Smissen WJC; Collée JM; Bolla MK; Wang Q; Michailidou K; Dennis J; Ahearn TU; Aittomäki K; Ambrosone CB; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Arnold N; Aronson KJ; Augustinsson A; Auvinen P; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bernstein L; Bogdanova NV; Bogdanova-Markov N; Bojesen SE; Brauch H; Brenner H; Briceno I; Brucker SY; Brüning T; Burwinkel B; Cai Q; Cai H; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Choi JY; Christiaens M; Clarke CL; ; Couch FJ; Czene K; Daly MB; Devilee P; Dos-Santos-Silva I; Dwek M; Eccles DM; Eliassen AH; Fasching PA; Figueroa J; Flyger H; Fritschi L; Gago-Dominguez M; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; Giles GG; Goldberg MS; Goldgar DE; Guénel P; Haiman CA; Håkansson N; Hall P; Harrington PA; Hart SN; Hartman M; Hillemanns P; Hopper JL; Hou MF; Hunter DJ; Huo D; ; Ito H; Iwasaki M; Jakimovska M; Jakubowska A; John EM; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kraft P; Kristensen VN; Kurian AW; Le Marchand L; Li J; Lindblom A; Lophatananon A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Mariapun S; Matsuo K; Maurer T; Mavroudis D; Meindl A; Menon U; Milne RL; Muir K; Mulligan AM; Neuhausen SL; Nevanlinna H; Offit K; Olopade OI; Olson JE; Olsson H; Orr N; Park SK; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Rack B; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Romero A; Ruebner M; Saloustros E; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Shen CY; Shu XO; Simard J; Sohn C; Southey MC; Spinelli JJ; Tamimi RM; Tapper WJ; Teo SH; Terry MB; Torres D; Truong T; Untch M; Vachon CM; van Asperen CJ; Wolk A; Yamaji T; Zheng W; Ziogas A; Ziv E; Torres-Mejía G; Dörk T; Swerdlow AJ; Hamann U; Schmidt MK; Dunning AM; Pharoah PDP; Easton DF; Hooning MJ; Martens JWM; Hollestelle A
    Sci Rep; 2020 Jun; 10(1):9688. PubMed ID: 32546843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic Interaction of
    Sipeky C; Gao P; Zhang Q; Wang L; Ettala O; Talala KM; Tammela TLJ; Auvinen A; Wiklund F; Wei GH; Schleutker J
    Clin Cancer Res; 2018 Dec; 24(24):6265-6276. PubMed ID: 30181389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review and meta-analysis of familial prostate cancer risk.
    Johns LE; Houlston RS
    BJU Int; 2003 Jun; 91(9):789-94. PubMed ID: 12780833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of prostate cancer in relatives of prostate cancer patients in Sweden: A nationwide cohort study.
    Xu X; Kharazmi E; Tian Y; Mukama T; Sundquist K; Sundquist J; Brenner H; Fallah M
    PLoS Med; 2021 Jun; 18(6):e1003616. PubMed ID: 34061847
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.